The first clinical trial of an Ebola vaccine in the outbreak gripping the Democratic Republic of Congo began Friday, the head of the World Health Organization said.

Kinshasa, DRC | URN | A vaccine trial targeting the Ebola Bundibugyo virus in the Democratic Republic of the Congo (DRC) is expected to begin shortly, raising hopes for new tools to combat an outbreak that has killed thousands of people and spread across multiple provinces. The trial, named Tumaini, meaning “hope” in Swahili, is …

The trial can test the safety, efficacy and immunogenicity of multiple vaccines. Read more at straitstimes.com.

A clinical trial for a new Ebola vaccine is getting underway in DR Congo’s Ituri province. The TUMAini trial will evaluate candidate vaccines against the Bundibugyo strain of the virus.

A clinical trial for a new Ebola vaccine is getting underway in DR Congo’s Ituri province. The TUMAini trial will evaluate candidate vaccines against the Bundibugyo strain of the virus.